![](/img/cover-not-exists.png)
Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients
Kojima, Toshihisa, Takahashi, Nobunori, Kaneko, Atsushi, Kida, Daihei, Hirano, Yuji, Fujibayashi, Takayoshi, Yabe, Yuichiro, Takagi, Hideki, Oguchi, Takeshi, Miyake, Hiroyuki, Kato, Takefumi, WatanabeLanguage:
english
Journal:
Clinical Rheumatology
DOI:
10.1007/s10067-015-3135-3
Date:
December, 2015
File:
PDF, 399 KB
english, 2015